- Home
- APLS vs TGLS Comparison
APLS vs TGLS Comparison
Compare APLS & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- TGLS
- Stock Information
- Founded
- APLS 2009
- TGLS 1984
- Country
- APLS United States
- TGLS Colombia
- Employees
- APLS N/A
- TGLS N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- TGLS Electronic Components
- Sector
- APLS Health Care
- TGLS Consumer Discretionary
- Exchange
- APLS Nasdaq
- TGLS Nasdaq
- Market Cap
- APLS 3.3B
- TGLS 3.9B
- IPO Year
- APLS 2017
- TGLS 2012
- Fundamental
- Price
- APLS $18.20
- TGLS $67.88
- Analyst Decision
- APLS Buy
- TGLS Buy
- Analyst Count
- APLS 18
- TGLS 5
- Target Price
- APLS $45.59
- TGLS $75.40
- AVG Volume (30 Days)
- APLS 2.8M
- TGLS 450.1K
- Earning Date
- APLS 05-06-2025
- TGLS 05-08-2025
- Dividend Yield
- APLS N/A
- TGLS 0.88%
- EPS Growth
- APLS N/A
- TGLS N/A
- EPS
- APLS N/A
- TGLS 3.43
- Revenue
- APLS $781,367,000.00
- TGLS $890,181,000.00
- Revenue This Year
- APLS $12.71
- TGLS $12.45
- Revenue Next Year
- APLS $20.93
- TGLS $8.59
- P/E Ratio
- APLS N/A
- TGLS $19.79
- Revenue Growth
- APLS 97.02
- TGLS 6.83
- 52 Week Low
- APLS $17.49
- TGLS $40.94
- 52 Week High
- APLS $53.06
- TGLS $86.99
- Technical
- Relative Strength Index (RSI)
- APLS 28.14
- TGLS 46.00
- Support Level
- APLS $18.00
- TGLS $66.49
- Resistance Level
- APLS $19.71
- TGLS $73.44
- Average True Range (ATR)
- APLS 1.63
- TGLS 3.97
- MACD
- APLS -0.16
- TGLS 0.00
- Stochastic Oscillator
- APLS 10.98
- TGLS 52.88
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About TGLS Tecnoglass Inc.
Tecnoglass Inc designs, manufactures, distributes, and markets architectural glass and windows. The company's products portfolio includes tempered, laminated, insulating and Solar Control Low-E glass. Its products are installed at hotels, residential buildings, commercial and corporate centers, airports and hospitals as floating facades, curtain walls, windows, doors, handrails, interior and dividers. Its majority of revenue is derived from the sale and installation of architectural glass and windows in the United States.